Olivier Brandicourt - 01 May 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: Director
Signature: Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol: PCVX
Transactions as of: 01 May 2025
Net transactions value: $0
Form type: 4
Filing time: 02 May 2025, 16:28:47 UTC
Previous filing: 07 Jun 2024
Next filing: 12 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BRANDICOURT OLIVIER	Director	C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS	Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact	02 May 2025	0001508518

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Award	$0	+40,113		$0.000000	40,113	01 May 2025	Common Stock	40,113	$35.24	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option shall vest over 36 months, 1/3 of which will vest on May 1, 2026 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.